Integration of immunomonitoring assays with PET/CT in TB patients identifies on-treatment biomarkers
Jingwen Fan, Vincent Rouilly, Munyaradzi Musvosvi, Marie Robert, Chloé Albert Vega, Vincent Bondet, Annika Jasper, Xiang Yu, Stephanus Theron Malherbe, Raphaël Borie, Nathan Peiffer‐Smadja, Karim Sacré, Benjamin Terrier, Gerhard Walzl, Clifton E. Barry, , Darragh Duffy
The paper identifies on-treatment biomarkers in TB patients by integrating immunomonitoring assays with PET/CT scans, showing significant cytokine changes and machine learning-based biomarkers for treatment response.
bioRxiv · May 14, 2026 · PreprintImmunology